Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma
How AssayQuant was used: This publication cites AssayQuant's PhosphoSens® technology.
ALK and ALK Mutants
Tyrosine kinase
Signaling biology
PhosphoSens